Author name: Leonardo Arias

Ralph Abraham, a vocal vaccine skeptic who served at the agency for just three months, has stepped down due to “unforeseen family obligations,” according to the CDC.

MetaSight uses metabolomics, lipidomics and proteomics mass spectrometry technologies to develop tests for specific diseases, including conditions outside of oncology.

Head-to-head trials are often reserved for approved therapies as drugmakers try to one-up each other to gain further market share. In this case, Novo Nordisk ran the test at the candidate stage, and the bet did not pay off.

The centerpiece of the takeover is anito-cel, a CAR T therapy under development for relapsed or refractory multiple myeloma. An FDA decision on the therapy is expected by December 2026.

A lower court had previously ruled for Sarepta in the companies’ long-running dispute, finding that REGENXBIO’s AAV patent was invalid because its elements were naturally occurring. The appeals court on Friday said that this original decision adopts a “narrow” view of the invention.

Bysanti is based on iloperidone, an active metabolite of a compound that forms the core of Fanapt, another drug by Vanda Pharmaceuticals.

Noticias de la actualidad astronómica y astronáutica del 23 de febrero de 2026.     …

En la historia de la ciencia moderna, algunos descubrimientos han transformado radicalmente nuestra comprensión del cosmos sin que sus protagonistas alcancen la fama de otros grandes nombres. Ese es el caso de Victor Franz Hess, el físico austríaco cuya audacia experimental perm …

  Hace tan solo una década, un sistema de Punto de Venta (POS) era poco más que una herramienta para procesar transacciones y guardar efectivo. Hoy, en 2026, esa definición parece prehistórica. La tecnología minorista ha avanzado a un ritmo vertiginoso, imp …

Discover how membership-style payment processing helps healthcare providers reduce fees, control costs, and simplify payments without compromising patient experience.